Literature DB >> 33640464

Adaptive responses to neurodegenerative stress in glaucoma.

David J Calkins1.   

Abstract

Glaucoma causes loss of vision through degeneration of the retinal ganglion cell (RGC) projection to the brain. The disease is characterized by sensitivity to intraocular pressure (IOP) conveyed at the optic nerve head, through which RGC axons pass unmyelinated to form the optic nerve. From this point, a pathogenic triumvirate comprising inflammatory, oxidative, and metabolic stress influence both proximal structures in the retina and distal structures in the optic projection. This review focuses on metabolic stress and how the optic projection may compensate through novel adaptive mechanisms to protect excitatory signaling to the brain. In the retina and proximal nerve head, the unmyelinated RGC axon segment is energy-inefficient, which leads to increased demand for adenosine-5'-triphosphate (ATP) at the risk of vulnerability to Ca2+-related metabolic and oxidative pressure. This vulnerability may underlie the bidirectional nature of progression. However, recent evidence highlights that the optic projection in glaucoma is not passive but rather demonstrates adaptive processes that may push back against neurodegeneration. In the retina, even as synaptic and dendritic pruning ensues, early progression involves enhanced excitability of RGCs. Enhancement involves depolarization of the resting membrane potential and increased response to light, independent of RGC morphological type. This response is axogenic, arising from increased levels and translocation of voltage-gated sodium channels (NaV) in the unmyelinated segment. During this same early period, large-scale networks of gap-junction coupled astrocytes redistribute metabolic resources to the optic projection stressed by elevated IOP to slow loss of axon function. This redistribution may reflect more local remodeling, as astrocyte processes respond to focal metabolic duress by boosting glycogen turnover in response to axonal activity in an effort to promote survival of the healthiest axons. Both enhanced excitability and metabolic redistribution are transient, indicating that the same adaptive mechanisms that apparently serve to slow progression ultimately may be too expensive for the system to sustain over longer periods.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adaptive remodeling; Astrocytes; Axon degeneration; Gap junctions; Glaucoma; Metabolic stress; Neurodegeneration; Oxidative stress

Mesh:

Year:  2021        PMID: 33640464      PMCID: PMC8384979          DOI: 10.1016/j.preteyeres.2021.100953

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   19.704


  176 in total

1.  Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation.

Authors:  Wenqin Hu; Cuiping Tian; Tun Li; Mingpo Yang; Han Hou; Yousheng Shu
Journal:  Nat Neurosci       Date:  2009-07-26       Impact factor: 24.884

2.  Differential progression of structural and functional alterations in distinct retinal ganglion cell types in a mouse model of glaucoma.

Authors:  Luca Della Santina; Denise M Inman; Caroline B Lupien; Philip J Horner; Rachel O L Wong
Journal:  J Neurosci       Date:  2013-10-30       Impact factor: 6.167

3.  Glaucomatous cupping of the human optic disk: a neuro-histologic study.

Authors:  F Vrabec
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-03-03

4.  Why do axons differ in caliber?

Authors:  János A Perge; Jeremy E Niven; Enrico Mugnaini; Vijay Balasubramanian; Peter Sterling
Journal:  J Neurosci       Date:  2012-01-11       Impact factor: 6.167

5.  Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress.

Authors:  Rebecca M Sappington; Tatiana Sidorova; Nicholas J Ward; Rohini Chakravarthy; Karen W Ho; David J Calkins
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

6.  Calpain activation in experimental glaucoma.

Authors:  Wei Huang; John Fileta; Ian Rawe; Juan Qu; Cynthia L Grosskreutz
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-27       Impact factor: 4.799

7.  Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric.

Authors:  Cassandra L Schlamp; Yan Li; Joel A Dietz; Katherine T Janssen; Robert W Nickells
Journal:  BMC Neurosci       Date:  2006-10-03       Impact factor: 3.288

8.  Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma.

Authors:  Wendi S Lambert; Brian J Carlson; Cathryn R Formichella; Rebecca M Sappington; Clarence Ahlem; David J Calkins
Journal:  Front Neurosci       Date:  2017-02-07       Impact factor: 4.677

9.  Glycogen synthase protects neurons from cytotoxicity of mutant huntingtin by enhancing the autophagy flux.

Authors:  Anupama Rai; Pankaj Kumar Singh; Virender Singh; Vipendra Kumar; Rohit Mishra; Ashwani Kumar Thakur; Anita Mahadevan; Susarla Krishna Shankar; Nihar Ranjan Jana; Subramaniam Ganesh
Journal:  Cell Death Dis       Date:  2018-02-08       Impact factor: 8.469

10.  Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin.

Authors:  Jeffrey M Harder; Chelsea Guymer; John P M Wood; Evangelia Daskalaki; Glyn Chidlow; Chi Zhang; Revathi Balasubramanian; Brynn H Cardozo; Nicole E Foxworth; Kelly E Deering; Tionna B Ouellette; Christa Montgomery; Craig E Wheelock; Robert J Casson; Pete A Williams; Simon W M John
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-14       Impact factor: 11.205

View more
  15 in total

1.  Single-cell transcriptome analysis of regenerating RGCs reveals potent glaucoma neural repair genes.

Authors:  Liang Li; Fang Fang; Xue Feng; Pei Zhuang; Haoliang Huang; Pingting Liu; Liang Liu; Adam Z Xu; Lei S Qi; Le Cong; Yang Hu
Journal:  Neuron       Date:  2022-08-10       Impact factor: 18.688

2.  Time-Frequency Analysis of ERG With Discrete Wavelet Transform and Matching Pursuits for Glaucoma.

Authors:  Marc Sarossy; Jonathan Crowston; Dinesh Kumar; Anne Weymouth; Zhichao Wu
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

Review 3.  Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration.

Authors:  Sara Al Hussein Al Awamlh; Lauren K Wareham; Michael L Risner; David J Calkins
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

4.  NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function.

Authors:  Fang Fang; Pei Zhuang; Xue Feng; Pingting Liu; Dong Liu; Haoliang Huang; Liang Li; Wei Chen; Liang Liu; Yang Sun; Haowen Jiang; Jiangbin Ye; Yang Hu
Journal:  Mol Ther       Date:  2022-01-31       Impact factor: 12.910

5.  Prediction of glaucoma severity using parameters from the electroretinogram.

Authors:  Marc Sarossy; Jonathan Crowston; Dinesh Kumar; Anne Weymouth; Zhichao Wu
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

6.  An Innovative In Vitro Open-Angle Glaucoma Model (IVOM) Shows Changes Induced by Increased Ocular Pressure and Oxidative Stress.

Authors:  Stefania Vernazza; Sara Tirendi; Mario Passalacqua; Francesco Piacente; Sonia Scarfì; Francesco Oddone; Anna Maria Bassi
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

7.  Gap Junctional Coupling Between Retinal Astrocytes Exacerbates Neuronal Damage in Ischemia-Reperfusion Injury.

Authors:  Abduqodir H Toychiev; Khulan Batsuuri; Miduturu Srinivas
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-11-01       Impact factor: 4.799

8.  Diabetes Exacerbates the Intraocular Pressure-Independent Retinal Ganglion Cells Degeneration in the DBA/2J Model of Glaucoma.

Authors:  Rosario Amato; Francesca Lazzara; Tsung-Han Chou; Giovanni Luca Romano; Maurizio Cammalleri; Massimo Dal Monte; Giovanni Casini; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-07-01       Impact factor: 4.799

9.  miRNA Changes in Retinal Ganglion Cells after Optic Nerve Crush and Glaucomatous Damage.

Authors:  Ben Mead; Alicia Kerr; Naoki Nakaya; Stanislav I Tomarev
Journal:  Cells       Date:  2021-06-22       Impact factor: 6.600

10.  Intraocular Delivery of a Collagen Mimetic Peptide Repairs Retinal Ganglion Cell Axons in Chronic and Acute Injury Models.

Authors:  Marcio Ribeiro; Nolan R McGrady; Robert O Baratta; Brian J Del Buono; Eric Schlumpf; David J Calkins
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.